[HTML][HTML] Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience
E Zanon, S Pasca, A Borchiellini, C Lodigiani… - Blood …, 2020 - ncbi.nlm.nih.gov
Background In 2016, a new recombinant B-domain deleted porcine FVIII (rpFVIII) was
licensed in Italy for the treatment of acquired haemophilia A (AHA), but only a few cases of …
licensed in Italy for the treatment of acquired haemophilia A (AHA), but only a few cases of …
[引用][C] Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience.
E Zanon, S Pasca, A Borchiellini, C Lodigiani… - BLOOD …, 2020 - iris.unipv.it
Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia
A: an Italian multicentre real world experience. IRIS IRIS Home Sfoglia Macrotipologie & …
A: an Italian multicentre real world experience. IRIS IRIS Home Sfoglia Macrotipologie & …
Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience
E Zanon, S Pasca, A Borchiellini… - Blood transfusion …, 2020 - pubmed.ncbi.nlm.nih.gov
Background In 2016, a new recombinant B-domain deleted porcine FVIII (rpFVIII) was
licensed in Italy for the treatment of acquired haemophilia A (AHA), but only a few cases of …
licensed in Italy for the treatment of acquired haemophilia A (AHA), but only a few cases of …
[PDF][PDF] Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience
E Zanon, S Pasca, A Borchiellini, C Lodigiani… - Blood …, 2020 - researchgate.net
Background-In 2016, a new recombinant B-domain deleted porcine FVIII (rpFVIII) was
licensed in Italy for the treatment of acquired haemophilia A (AHA), but only a few cases of …
licensed in Italy for the treatment of acquired haemophilia A (AHA), but only a few cases of …
Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience
E Zanon, S Pasca, A Borchiellini… - BLOOD …, 2020 - research.unipd.it
Background-In 2016, a new recombinant B-domain deleted porcine FVIII (rpFVIII) was
licensed in Italy for the treatment of acquired haemophilia A (AHA), but only a few cases of …
licensed in Italy for the treatment of acquired haemophilia A (AHA), but only a few cases of …
Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience.
E Zanon, S Pasca, A Borchiellini… - Blood Transfusion …, 2020 - europepmc.org
Background In 2016, a new recombinant B-domain deleted porcine FVIII (rpFVIII) was
licensed in Italy for the treatment of acquired haemophilia A (AHA), but only a few cases of …
licensed in Italy for the treatment of acquired haemophilia A (AHA), but only a few cases of …
Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience
E Zanon, S Pasca, A Borchiellini, C Lodigiani… - Blood …, 2020 - bloodtransfusion.it
Background-In 2016, a new recombinant B-domain deleted porcine FVIII (rpFVIII) was
licensed in Italy for the treatment of acquired haemophilia A (AHA). But only a few cases of …
licensed in Italy for the treatment of acquired haemophilia A (AHA). But only a few cases of …
[PDF][PDF] Susoctocog-alfa (Obizur®) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experience
E Zanon, S Pasca, A Borchiellini, C Lodigiani… - researchgate.net
Background-In 2016, a new recombinant B-domain deleted porcine FVIII (rpFVIII) was
licensed in Italy for the treatment of acquired haemophilia A (AHA). But only a few cases of …
licensed in Italy for the treatment of acquired haemophilia A (AHA). But only a few cases of …